Guy Macdonald

Insider profile

Currently holds positions in SCYNEXIS Inc and Tetraphase Pharmaceuticals Inc

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 19% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director SCYNEXIS Inc Nov. 27, 2014 -
Director Tetraphase Pharmaceuticals Inc Aug. 1, 2019 -
President and Chief Executive Officer, Director Tetraphase Pharmaceuticals Inc Jan. 1, 2008 - Aug. 1, 2019
Guy Macdonald's trades of SCYNEXIS Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US SCYNEXIS Inc (SCYX)
Transaction date
Purchase
Price
487.50
Quantity 26,356 +34.1%
Value US$4,347,395
Transaction date
Purchase
Price
411.50
Quantity 4,933 +28.2%
Value US$1,495,345
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-12-23 2020-12-21
US SCYNEXIS Inc (SCYX)
B Purchase
26,356 +34.1%
487.50
US$4,347,395 		26,356 +34.1% 487.50 US$4,347,395
2004-07-29 2004-07-27
B Purchase
4,933 +28.2%
411.50
US$1,495,345 		4,933 +28.2% 411.50 US$1,495,345